The prognostic impact of HF etiology appears phenotype-dependent, concentrated within HFmrEF, where non-ischemic etiology substantially worse survival, and warrants confirmation.
M. Tarnowski, Karolina Molenda, R. Morawiec et al.· Archives of Medical Science· 0 citations
ADONIS-PCI is among the first randomized evaluations of a reduced-dose long-term ticagrelor strategy combined with dabigatran in patients with AF and ACS undergoing PCI, addressing an important evidence gap in the selection and dosing of P2Y12 inhibition when aspirin is discontinued early in this high-risk population.
M. Jaguszewski, Aleksandra Gąsecka-van der Pol, N. Gilis-Malinowska et al.· Cardiology Journal· 0 citations
Clinical characteristics associated with failure to achieve the prespecified stringent GDMT target included sex, age, body mass index, anaemia, renal function, and de novo HF diagnosis and associations with treatment intensity at discharge are described.
A. Galas, R. Morawiec, I. Gorczyca-Głowacka et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.